Ming Shi

4.3k total citations
107 papers, 2.6k citations indexed

About

Ming Shi is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Ming Shi has authored 107 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 41 papers in Molecular Biology and 15 papers in Immunology. Recurrent topics in Ming Shi's work include CAR-T cell therapy research (23 papers), Cancer, Stress, Anesthesia, and Immune Response (12 papers) and CRISPR and Genetic Engineering (11 papers). Ming Shi is often cited by papers focused on CAR-T cell therapy research (23 papers), Cancer, Stress, Anesthesia, and Immune Response (12 papers) and CRISPR and Genetic Engineering (11 papers). Ming Shi collaborates with scholars based in China, United States and Panama. Ming Shi's co-authors include Ning Guo, Liang Guo, Dan Liu, Qian Lu, Po Tien, Feng Shi, Ruizhao Qi, Yongping Yang, Fu‐Sheng Wang and Zhen Zeng and has published in prestigious journals such as Nature Communications, Blood and The Journal of Immunology.

In The Last Decade

Ming Shi

98 papers receiving 2.5k citations

Peers

Countries citing papers authored by Ming Shi

Since Specialization

Citations

This map shows the geographic impact of Ming Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Shi more than expected).

Fields of papers citing papers by Ming Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Shi. The network helps show where Ming Shi may publish in the future.

Co-authorship network of co-authors of Ming Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Shi. A scholar is included among the top collaborators of Ming Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Shi. Ming Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	IFN-γ-mediated suppression of Caspase-7 exacerbates acute lung injury induced by CAR-T cells 2025 ·Molecular Therapy ·(unknown), (unknown), Zejun Zhang, Wenyin He, Huan Li, Xu An Wang, Xuan Zhao, Sijin Li, (unknown), Ying Sun, Shilin Liu, Junnian Zheng, Ming Shi	1
2	Advances in CAR optimization strategies based on CD28 2025 ·Frontiers in Immunology ·Sijin Li, Yongning Zhou, Hairong Wang, (unknown), Xuan Zhao, Xu Wang, (unknown), (unknown), Dan Liu, Junnian Zheng, Ming Shi	0
3	Association between remnant cholesterol and the risk of 4 site-specific cancers: evidence from a cross-sectional and Mendelian randomization study 2024 ·Lipids in Health and Disease ·Mengjie Li, Qi Liu, Ming Shi, (unknown), (unknown)	2
4	In vivo manufacture and manipulation of CAR-T cells for better druggability 2024 ·Cancer and Metastasis Reviews ·(unknown), Xiaoxue Zhang, Xu Wang, Xuan Zhao, Sijin Li, (unknown), Jiang Cao, Dan Liu, Junnian Zheng, Ming Shi	12
5	Long noncoding RNA NONHSAT160169.1 promotes resistance via hsa-let-7c-3p/SOX2 axis in gastric cancer 2023 ·Scientific Reports ·Xuan Zhao, Zijian Xu, (unknown), (unknown), (unknown), (unknown), (unknown), Wen Ma, Dan Liu, Junnian Zheng, Ming Shi	3
6	A combination of pre-infusion serum ferritin, CRP and IL-6 predicts outcome in relapsed/refractory multiple myeloma patients treated with CAR-T cells 2023 ·Frontiers in Immunology ·Yang Liu, (unknown), Nian Li, Ying Wang, Congyue Wang, Jin Ma, (unknown), Qingyun Wu, Jianlin Qiao, Wei Chen, Jiang Cao, Zhiling Yan, Ming Shi, Hai Cheng, Feng Zhu, Wei Sang, Depeng Li, Chong Chen, Kailin Xu, Zhenyu Li	17
7	Analytical solution for deep non-circular tunnels considering slippage effects under far-field seismic SV waves 2023 ·Tunnelling and Underground Space Technology ·Cheng Shi, Lianjin Tao, Peng Ding, Zhigang Wang, (unknown), Ming Shi	11
8	DddA homolog search and engineering expand sequence compatibility of mitochondrial base editing 2023 ·Nature Communications ·Mi Li, Ming Shi, Yuxuan Li, (unknown), Xichen Rao, (unknown), (unknown), (unknown), (unknown), (unknown), Ning Gao, Wensheng Wei, Xianhua Wang, Yangming Wang	38
9	From rough to precise: PD-L1 evaluation for predicting the efficacy of PD-1/PD-L1 blockades 2022 ·Frontiers in Immunology ·Xuan Zhao, (unknown), (unknown), (unknown), Sijin Li, Xu Wang, (unknown), Wen Ma, Dan Liu, Junnian Zheng, Ming Shi	35
10	KLF17 promotes human naive pluripotency through repressing MAPK3 and ZIC2 2022 ·Science China Life Sciences ·Shaohua Wang, Jing Hao, (unknown), (unknown), (unknown), Ming Shi, Xin Huang, Jihong Yang, Huiqing Cao, Yangming Wang	6
11	Predictive role of endothelial cell activation in cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukaemia 2021 ·Journal of Cellular and Molecular Medicine ·Fei Hong, Ming Shi, Jiang Cao, Ying Wang, Yanqing Gong, (unknown), Zhenyu Li, Junnian Zheng, Lingyu Zeng, Aili He, Kailin Xu	23
12	Combined Treatment of Radiotherapy and Immunotherapy for Urological Malignancies: Current Evidence and Clinical Considerations 2021 ·Cancer Management and Research ·(unknown), Ming Shi, Hang Xu, (unknown), Xingyu Xiong, Qiang Wei, Lu Yang	7
13	β2‐AR activation promotes cleavage and nuclear translocation of Her2 and metastatic potential of cancer cells 2020 ·Cancer Science ·Dan Liu, Li Zha, Yuchen Liu, Xuan Zhao, (unknown), Shuci Liu, Wen Ma, Junnian Zheng, Ming Shi	15
14	Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion >5%: a propensity score matching analysis from SEER database 2019 ·Scientific Reports ·Junru Chen, Zhipeng Wang, Jinge Zhao, Sha Zhu, Guangxi Sun, Jiandong Liu, Haoran Zhang, Xingming Zhang, Pengfei Shen, Ming Shi, Hao Zeng	18
15	β2-AR signaling controls trastuzumab resistance-dependent pathway 2015 ·Oncogene ·(unknown), Zhengyan Yang, (unknown), (unknown), Yi Hu, Chao Hu, Liang Guo, (unknown), Yijin Liu, Ming‐Sun Yu, Ming Shi, Ning Du, Ning Guo	75
16	A Her2-let-7-β2-AR circuit affects prognosis in patients with Her2-positive breast cancer 2015 ·BMC Cancer ·Dan Liu, (unknown), Limin Sun, Tao Wang, Zhengyan Yang, Hongyu Chen, Liang Guo, (unknown), Yuanfang Ma, Ning Guo, Ming Shi	24
17	Adrenergic signaling promotes angiogenesis through endothelial cell-tumor cell crosstalk 2014 ·Endocrine Related Cancer ·Y-H. Chen, Dan Liu, Zhao-Xu Yang, Limin Sun, (unknown), Shun‐Fa Yang, Lei Qian, Liang Guo, Ming Yu, Min Hu, Ming Shi, Ning Guo	65
18	The β2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells 2010 ·Breast Cancer Research and Treatment ·Ming Shi, Dan Liu, Huijun Duan, Qian Lu, Lina Wang, (unknown), (unknown), (unknown), Ze‐Hui Gong, Lun Song, Ming Yu, Meiru Hu, Qing Xia, Bing Shen, Ning Guo	109
19	PD‐1 and PD‐L1 upregulation promotes CD8⁺ T‐cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients 2010 ·International Journal of Cancer ·Feng Shi, Ming Shi, Zhen Zeng, Ruizhao Qi, (unknown), Ji‐Yuan Zhang, Yongping Yang, Po Tien, Fu‐Sheng Wang	371
20	De novo design of ErbB2 epitope targeting fusion protein stabilized by coiled coil structure 2007 ·Molecular Immunology ·Jianing Wang, Jiannan Feng, Ming Shi, Qian Lu, Liyong Chen, Ming Yu, Ruonan Xu, Bing Shen, Ning Guo	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liang Guo Breakdown of academic impact, for papers by Huafeng Wei Breakdown of academic impact, for papers by Dmitriy Lukashev Breakdown of academic impact, for papers by Seiji Nomura Breakdown of academic impact, for papers by Sergey Apasov Breakdown of academic impact, for papers by Iris Helfrich Breakdown of academic impact, for papers by Kenji Nakano Breakdown of academic impact, for papers by Hao‐Wei Wang